Adverse Drug Reaction in the Neonatal Intensive Care Unit: A Single Center Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Little research has been conducted on adverse drug reactions in neonates, particularly in Korea, where no studies have been reported. Methods: We conducted a retrospectively study using medical records in a neonatal intensive care unit from August 1, 2013 to July 31, 2014. The adverse drug reactions were evaluated according to the Naranjo algorithm, World Health Organization-Uppsala Monitoring Centre, and the Korean adverse drug reaction algorithm. Results: Of the 410 infants hospitalized during the study period, 57 cases of adverse drug reactions were reported in 40 infants (9.8%). The average gestational age was 28.4±4.3 weeks, the average birth weight was 1,184.1±622.0 g, and the adverse drug reactions were reported at an average of 21.0±29.7 days after birth. Causative agents were identified as electrolytes (36.8%), respiratory medication (14.0%), total parenteral nutrition (12.3%), lipid emulsion (10.5%), antibiotics (7.0%), non-steroidal anti-inflammatory drugs (NSAIDs, 7.0%), sedatives (7.0%), vaccine (3.5%), and an antiviral medication (1.8%). Of the 57 cases, 55 (96.5%) cases demonstrated meaningful adverse drug reactions, defined as those given a score of “possible or above” in all 3 adverse drug reaction algorithms. Conclusion: More emphasis is warranted in the field of neonatal adverse drug reactions.
Abstract
Purpose: Little research has been conducted on adverse drug reactions in neonates, particularly in Korea, where no studies have been reported. Methods: We conducted a retrospectively study using medical records in a neonatal intensive care unit from August 1, 2013 to July 31, 2014. The adverse drug reactions were evaluated according to the Naranjo algorithm, World Health Organization-Uppsala Monitoring Centre, and the Korean adverse drug reaction algorithm. Results: Of the 410 infants hospitalized during the study period, 57 cases of adverse drug reactions were reported in 40 infants (9.8%). The average gestational age was 28.4±4.3 weeks, the average birth weight was 1,184.1±622.0 g, and the adverse drug reactions were reported at an average of 21.0±29.7 days after birth. Causative agents were identified as electrolytes (36.8%), respiratory medication (14.0%), total parenteral nutrition (12.3%), lipid emulsion (10.5%), antibiotics (7.0%), non-steroidal anti-inflammatory drugs (NSAIDs, 7.0%), sedatives (7.0%), vaccine (3.5%), and an antiviral medication (1.8%). Of the 57 cases, 55 (96.5%) cases demonstrated meaningful adverse drug reactions, defined as those given a score of “possible or above” in all 3 adverse drug reaction algorithms. Conclusion: More emphasis is warranted in the field of neonatal adverse drug reactions.
참고문헌 (23)
- Du W, "An algorithm to detect adverse drug reactions in the neonatal intensive care unit", J Clin Pharmacol, 53, pp.87~95 (2013)
- Edwards IR, "Adverse drug reactions: definitions, diagnosis, and management", Lancet, 356, pp.1255~1259 (2000)
- Impicciatore P, "Incidence of adverse drug reactions in paediatric in", out-patients: a systematic review and meta-analysis of prospective studies, 2001, pp.52, 77~83
- Fabiano V, "Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future", Expert Opin Drug Saf, 11, pp.95~105 (2012)
- Kaushal R, "Medication errors in paediatric outpatients", Qual Saf Health Care, 19, pp.e30~ (2010)
- Aranda JV, "Drug utilization in a newborn intensive care unit", J Pediatr, 89, pp.315~317 (1976)
- Aranda JV, "Epidemiology of adverse drug reactions in the newborn", Dev Pharmacol Ther, 5, pp.173~184 (1982)
- Johnson PJ, "Neonatal pharmacology--pharmacokinetics", Neonatal Netw, 30, pp.54~61 (2011)
- Warrier I, "Patterns of drug utilization in a neonatal intensive care unit", J Clin Pharmacol, 46, pp.449~455 (2006)
- Pandolfini C, "A literature review on off-label drug use in children", Eur J Pediatr, 164, pp.552~558 (2005)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- 홍경섭, "약물이상반응의 인과성 평가를 위한 한국형 알고리즘의 개발", Translational and Clinical Pharmacology, 10(2), pp.129~142 (2002), 대한임상약리학회
- 류성윤, "단일 대학병원 약물유해반응의 보고 및 임상양상", 천식 및 알레르기, 31(3), pp.184~191 (2011), 대한천식알레르기학회
- Knight M, "Adverse drug reactions in neonates", J Clin Pharmacol, 34, pp.128~135 (1994)
- Gurwitz JH, "Incidence and preventability of adverse drug events among older persons in the ambulatory setting", JAMA, 289, pp.1107~1116 (2003)
- Strolin Benedetti M, "Drug metabolism and disposition in children", Fundam Clin Pharmacol, 17, pp.281~299 (2003)
- Ehrnebo M, "Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults", Eur J Clin Pharmacol, 3, pp.189~193 (1971)
- Kearns GL, "Developmental pharmacology--drug disposition, action, and therapy in infants and children", N Engl J Med, 349, pp.1157~1167 (2003)
- Le J, "Adverse drug reactions among children over a 10-year period", Pediatrics, 118, pp.555~562 (2006)
- Agarwal S, "Prevalence of adverse events in pediatric intensive care units in the United States", Pediatr Crit Care Med, 11, pp.568~578 (2010)
- 이나용, "산전 황산마그네슘 노출이 자간전증 산모에서 태어난 극소 저체중 출생아의 주산기 예후에 미치는 영향", Neonatal medicine, 20(1), pp.28~34 (2013), 대한신생아학회
- Aldea A, "Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009", Eur J Clin Pharmacol, 68, pp.1329~1338 (2012)
- Aagaard L, "Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007", Drug Saf, 33, pp.327~339 (2010)